Supplementary data from PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer
Roman M. Chabanon(Université Paris-Sud), Sophie Postel‐Vinay(Université Paris-Sud)
Cited by 0
Related Papers
PARP inhibition enhances tumor cell–intrinsic immunity in ERCC1-deficient non–small cell lung cancer
|Journal of Clinical Investigation|2018|322
Large-Scale Profiling of Kinase Dependencies in Cancer Cell Lines
|Cell Reports|2016|109
DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade
|Journal of Clinical Investigation|2018|29